Astrid Jullion

Person

Sierentz, FR

People

Patents Grantslast 30 patents

Information Patent Grant
Dose and regimen for HDM2-p53 interaction inhibitors
- Patent number 10,966,978
- Issue date Apr 6, 2021
- Novartis AG
- Stephane Ferretti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
DOSING REGIMEN FOR TREATING A DISEASE MODULATED BY CSF-1R
- Publication number 20230172920
- Publication date Jun 8, 2023
- Novartis AG
- Astrid JULLION
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Combinations
- Publication number 20220281970
- Publication date Sep 8, 2022
- Novartis AG
- Nelson Guerreiro
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Dose and regimen for an hdm2-p53 interaction inhibitor in hematolog...
- Publication number 20220031697
- Publication date Feb 3, 2022
- Novartis AG
- Stephane FERRETTI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMBINATIONS
- Publication number 20210386763
- Publication date Dec 16, 2021
- Novartis AG
- Nelson GUERREIRO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMBINATIONS
- Publication number 20210363254
- Publication date Nov 25, 2021
- Novartis AG
- Stephane FERRETTI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Dose and regimen for an hdm2-p53 interaction inhibitor in hematolog...
- Publication number 20200281925
- Publication date Sep 10, 2020
- Novartis AG
- Stephane FERRETTI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Dose and regimen for hdm2-p53 interaction inhibitors
- Publication number 20190298719
- Publication date Oct 3, 2019
- Novartis AG
- Stephane Ferretti
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Astrid Jullion

Person

Patents Grantslast 30 patents

Dose and regimen for HDM2-p53 interaction inhibitors

Patents Applicationslast 30 patents

DOSING REGIMEN FOR TREATING A DISEASE MODULATED BY CSF-1R

Pharmaceutical Combinations

Dose and regimen for an hdm2-p53 interaction inhibitor in hematolog...

PHARMACEUTICAL COMBINATIONS

PHARMACEUTICAL COMBINATIONS

Dose and regimen for an hdm2-p53 interaction inhibitor in hematolog...

Dose and regimen for hdm2-p53 interaction inhibitors